|
Index of reports
> All cases (253)
Below is the selection of adverse event reports related to Aldactone (Spironolactone) that includes all cases.
Reports 1 - 25 of 253 Next >>
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a individual with unspecified qualification from Brazil on 2007-10-30
Patient: female
Adverse reactions / side effects: Drug Ineffective, Impaired Work Ability, Ill-Defined Disorder, Palpitations, Diarrhoea, Pulmonary Oedema, Oedema, Arterial Occlusive Disease, Depression, Myocardial Infarction, Blood Glucose Increased, Haematoma
Adverse event resulted in: disablity
Suspect drug(s):
Olmesartan Medoxomil
Dosage: 20 mg (20 mg,qd),per oral
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
Diabinese
Dosage: 500 mg (250 mg,bid),per oral
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 1996-01-01
End date: 2004-11-30
Norvasc
Dosage: 5 mg (5 mg,qd),per oral
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2004-01-01
End date: 2006-01-01
Caduet
Dosage: 10/5 mg (bid),per oral
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
Aldactone
Dosage: (qd), per oral
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
Coristina D (Acetysalicylic Acid, Cafffeine, Phenylephrine Hydrochlori
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Insulin (Insulin) (-Injection) (Insulin)
Adverse event in receiving Aldactone (Spironolactone)
Reported by a consumer/non-health professional from France on 2007-10-29
Patient:
Adverse reactions / side effects: Blood Urea Increased, Overdose, Drug Interaction, Blood Creatinine Increased, Renal Failure Acute
Adverse event resulted in: hospitalization
Suspect drug(s):
Ramipril
Dosage: 2.5 mg, bid
Administration route: Oral
End date: 2007-09-08
Lasix
Dosage: 40 mg, bid
Administration route: Oral
End date: 2007-09-08
Aldactone
Dosage: 250 mg, qd
Administration route: Oral
End date: 2007-09-08
Other drugs received by patient: Ditropan / 00538901 /; Escitalopram; Ogast; Previscan / 00789001 /; Lyrica; Havlane; Novomix / 01475801 /
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a consumer/non-health professional from Brazil on 2007-10-26
Patient: female
Adverse reactions / side effects: Syncope, Dyspnoea, Injection Site Haematoma, Coagulopathy, Oedema, Arterial Occlusive Disease, Pulmonary Oedema, Depression, Myocardial Infarction, Blood Glucose Increased
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Diabinese
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 1996-01-01
End date: 2004-11-30
Norvasc
Administration route: Oral
Start date: 2004-01-01
End date: 2006-01-01
Caduet
Dosage: text:10mg/5mg;20mg/10mg
Administration route: Oral
Indication: Hypertension
Aldactone
Administration route: Oral
Indication: Hypertension
Olmetec
Administration route: Oral
Indication: Hypertension
Coristina D
Administration route: Oral
Indication: Influenza
Insulin
Indication: Diabetes Mellitus
Start date: 2004-11-01
Novonorm
Adverse event in 71 year old male receiving Aldactone (Spironolactone)
Reported by a physician from France on 2007-10-24
Patient: 71 year old male, weighing 58.0 kg (127.6 pounds)
Adverse reactions / side effects: Toxic Epidermal Necrolysis
Adverse event resulted in: death
Suspect drug(s):
Lasix
Administration route: Oral
Start date: 2007-01-27
End date: 2007-02-11
Claforan
Start date: 2007-02-05
End date: 2007-02-09
Aldactone
Administration route: Oral
Start date: 2007-01-27
End date: 2007-02-11
Efferalgan / 00020001 /
Administration route: Oral
Start date: 2007-01-31
End date: 2007-02-09
Ciflox / 00697201 /
Administration route: Oral
Start date: 2007-02-09
End date: 2007-02-10
Inipomp / 01263201 /
Administration route: Oral
Start date: 2007-02-06
End date: 2007-02-11
Other drugs received by patient: Solupred / 00016201 /; Aerius / 01398501 /; Atarax / 00058402 /; Propranolol Hydrochloride; Mycostatin
Adverse event in male receiving Aldactone (Spironolactone)
Reported by a individual with unspecified qualification from United States on 2007-10-24
Patient: male, weighing 95.0 kg (209.0 pounds)
Adverse reactions / side effects: Renal Failure, Diabetes Mellitus, Hypotension, Cardiac Failure Congestive
Adverse event resulted in: hospitalization
Suspect drug(s):
Bibr 1048 (Dabigatran Etexilate) (Blind)
Administration route: Oral
Indication: Cerebrovascular Accident Prophylaxis
Bibr 1048 (Dabigatran Etexilate) (Blind)
Indication: Thrombosis Prophylaxis
Lasix
Administration route: Oral
Indication: Hypertension
Lasix
Indication: Cardiac Failure Congestive
Vasotec
Administration route: Oral
Indication: Hypertension
Vasotec
Indication: Cardiac Failure Congestive
Digoxin
Administration route: Oral
Indication: Ischaemic Cardiomyopathy
Aldactone
Administration route: Oral
Indication: Hypertension
Other drugs received by patient: Levemir; Digitek
Adverse event in male receiving Aldactone (Spironolactone)
Reported by a physician from United States on 2007-10-23
Patient: male
Adverse reactions / side effects: Renal Failure, Hypotension, Cardiac Failure Congestive
Adverse event resulted in: hospitalization
Suspect drug(s):
Aldactone
Dosage: daily dose:25mg-freq:frequency: 25mg, qod
Administration route: Oral
Indication: Hypertension
Blinded Spironolactone
Administration route: Oral
Indication: Prophylaxis
Blinded Spironolactone
Indication: Embolism
Lasix
Dosage: daily dose:40mg
Administration route: Oral
Indication: Hypertension
Lasix
Indication: Cardiac Failure Congestive
Vasotec
Dosage: daily dose:10mg
Administration route: Oral
Indication: Hypertension
Vasotec
Indication: Cardiac Failure Congestive
Digoxin
Dosage: daily dose:.125mg
Administration route: Oral
Indication: Ischaemic Cardiomyopathy
Adverse event in male receiving Aldactone (Spironolactone)
Reported by a lawyer from Norway on 2007-10-23
Patient: male
Adverse reactions / side effects: Dyspepsia, Nausea, Dizziness, Visual Acuity Reduced, Erectile Dysfunction, Gynaecomastia, Meniere's Disease
Suspect drug(s):
Aldactone
Indication: Hypertension
Start date: 1997-01-01
End date: 1999-01-01
Aldactone
Indication: Hyperaldosteronism
Adverse event in 52 year old male receiving Aldactone (Spironolactone)
Reported by a health professional (non-physician/pharmacist) from France on 2007-10-23
Patient: 52 year old male
Adverse reactions / side effects: Phlebitis, Pulmonary Embolism
Adverse event resulted in: hospitalization
Suspect drug(s):
Aldactone
Administration route: Oral
Indication: Nephrotic Syndrome
Thalidomide
Administration route: Oral
Indication: Multiple Myeloma
Lasix
Administration route: Oral
Indication: Nephrotic Syndrome
Triatec
Administration route: Oral
Indication: Nephrotic Syndrome
Other drugs received by patient: Alkeran; Dexamethasone
Adverse event in male receiving Aldactone (Spironolactone)
Reported by a physician from Australia on 2007-10-19
Patient: male, weighing 130.0 kg (286.0 pounds)
Adverse reactions / side effects: Pulmonary Hypertension, Dyspnoea, Pneumonia, Anaemia, Encephalopathy, Tricuspid Valve Incompetence, Surgery, Cardiac Failure, Mitral Valve Incompetence, Oedema Peripheral, Sleep Apnoea Syndrome, Alcohol Problem
Suspect drug(s):
Aldactone
Administration route: Oral
Indication: Oedema
Lipitor
Dosage: daily dose:20mg
Administration route: Oral
Indication: Hyperlipidaemia
Other drugs received by patient: Atacand; Lasix; Dilatrend; Endep; Warfarin Sodium; Zyloprim; Diaformin
Adverse event in 71 year old male receiving Aldactone (Spironolactone)
Reported by a physician from France on 2007-10-19
Patient: 71 year old male, weighing 58.0 kg (127.6 pounds)
Adverse reactions / side effects: Toxic Epidermal Necrolysis
Adverse event resulted in: death
Suspect drug(s):
Claforan
Start date: 2007-02-05
End date: 2007-02-09
Lasix
Administration route: Oral
Start date: 2007-01-27
End date: 2007-02-11
Aldactone
Administration route: Oral
Start date: 2007-01-27
End date: 2007-02-11
Efferalgan / 00020001 /
Administration route: Oral
Start date: 2007-01-31
End date: 2007-02-09
Ciflox / 00697201 /
Administration route: Oral
Start date: 2007-02-09
End date: 2007-02-10
Inipomp / 01263201 /
Administration route: Oral
Start date: 2007-02-06
End date: 2007-02-11
Other drugs received by patient: Solupred / 00016201 /; Aerius / 01398501 /; Atarax / 00058402 /; Propranolol Hydrochloride; Mycostatin
Adverse event in 65 year old male receiving Aldactone (Spironolactone)
Reported by a physician from United States on 2007-10-18
Patient: 65 year old male
Adverse reactions / side effects: Renal Failure, Hypotension
Adverse event resulted in: hospitalization
Suspect drug(s):
Lasix
Administration route: Oral
Indication: Hypertension
Lasix
Administration route: Oral
Aldactone
Administration route: Oral
Indication: Hypertension
Antithrombotic Agents
Dosage: dose: unk
Antithrombotic Agents
Dosage: dose: unk
Vasotec / 00935901 /
Administration route: Oral
Indication: Hypertension
Vasotec / 00935901 /
Administration route: Oral
Digoxin
Administration route: Oral
Adverse event in receiving Aldactone (Spironolactone)
Reported by a consumer/non-health professional from France on 2007-10-17
Patient:
Adverse reactions / side effects: Hypotension, Rectal Haemorrhage, Gastric Ulcer
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace
Dosage: 1 u, qd
Administration route: Oral
Indication: Hypertension
Lasix
Dosage: 40 mg, qd
Administration route: Oral
Indication: Cardiac Failure
Previscan / 00789001 /
Dosage: 25 mg, qd
Administration route: Oral
Indication: Thrombosis
End date: 2006-10-13
Previscan / 00789001 /
Start date: 2006-10-15
Aldactone
Dosage: 1 u film-coated tablet
Administration route: Oral
Indication: Cardiac Failure
Elisor
Dosage: 1 u tablet,qd
Administration route: Oral
Indication: Hypercholesterolaemia
Adverse event in 71 year old male receiving Aldactone (Spironolactone)
Reported by a individual with unspecified qualification on 2007-10-17
Patient: 71 year old male
Adverse reactions / side effects: Drug Interaction, Renal Failure Acute
Adverse event resulted in: hospitalization
Suspect drug(s):
Ramipril
Administration route: Oral
End date: 2007-09-08
Lasix
Administration route: Oral
End date: 2007-09-08
Aldactone
Administration route: Oral
End date: 2007-09-08
Other drugs received by patient: Ditropan; Escitalopram; Ogast; Previscan / 00789001 /; Lyrica; Havlane; Novomix / 01475801 /
Adverse event in male receiving Aldactone (Spironolactone)
Reported by a health professional (non-physician/pharmacist) from France on 2007-10-16
Patient: male
Adverse reactions / side effects: Malaise, Hyperkalaemia, Bundle Branch Block
Adverse event resulted in: hospitalization
Suspect drug(s):
Atacand
Administration route: Oral
Aldactone
Administration route: Oral
End date: 2006-10-17
Lasix
Administration route: Oral
Other drugs received by patient: Tahor; Metformin
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a consumer/non-health professional from United States on 2007-10-15
Patient: female, weighing 61.4 kg (135.0 pounds)
Adverse reactions / side effects: Bone Neoplasm Malignant, Renal Failure, Cardiac Failure, Hypotension, Oedema Peripheral, Tachycardia
Adverse event resulted in: death
Suspect drug(s):
Aldactone
Indication: Cardiac Failure Congestive
Start date: 2006-11-01
End date: 2007-03-01
Aldactone
Indication: Hypertension
Metoprolol
Lasix
Other drugs received by patient: Fentanyl
Adverse event in 62 year old female receiving Aldactone (Spironolactone)
Reported by a physician from Japan on 2007-10-12
Patient: 62 year old female
Adverse reactions / side effects: Pulmonary Embolism, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Aldactone (Spironolactone)
Other drugs received by patient: NU Lotan; Mercazole
Adverse event in 70 year old male receiving Aldactone (Spironolactone)
Reported by a physician from Japan on 2007-10-12
Patient: 70 year old male
Adverse reactions / side effects: Interstitial Lung Disease
Adverse event resulted in: hospitalization
Suspect drug(s):
Lansoprazole
Administration route: Oral
Start date: 2007-05-11
End date: 2007-06-13
Lasix
Administration route: Oral
Indication: Cardiac Failure
Start date: 2007-05-11
End date: 2007-06-13
Artist
Administration route: Oral
Indication: Cardiac Failure
Start date: 2007-05-15
End date: 2007-06-13
Renivace
Administration route: Oral
Indication: Cardiac Failure
Start date: 2007-05-06
End date: 2007-06-13
Amlodipine
Administration route: Oral
Indication: Cardiac Failure
Start date: 2007-05-09
End date: 2007-06-13
Magmit
Administration route: Oral
Indication: Constipation
Start date: 2007-05-09
End date: 2007-06-13
Aldactone
Administration route: Oral
Indication: Cardiac Failure
Start date: 2007-05-14
End date: 2007-06-13
Other drugs received by patient: Aspirin; Ticlopidine HCL
Adverse event in male receiving Aldactone (Spironolactone)
Reported by a physician from United Kingdom on 2007-10-12
Patient: male
Adverse reactions / side effects: Blood Testosterone Decreased, Erectile Dysfunction
Suspect drug(s):
Aldactone (Spironolactone)
Adverse event in 72 year old male receiving Aldactone (Spironolactone)
Reported by a individual with unspecified qualification on 2007-10-11
Patient: 72 year old male
Adverse reactions / side effects: Malaise, Hyperkalaemia, Bundle Branch Block
Adverse event resulted in: hospitalization
Suspect drug(s):
Lasix
Administration route: Oral
Aldactone
Administration route: Oral
End date: 2006-10-17
Atacand
Administration route: Oral
Other drugs received by patient: Tahor; Metformin HCL; Amlor
Adverse event in 46 year old female receiving Aldactone (Spironolactone)
Reported by a pharmacist from Japan on 2007-10-06
Patient: 46 year old female
Adverse reactions / side effects: Breast Swelling, Metrorrhagia
Suspect drug(s):
Aldactone (Spironolactone)
Other drugs received by patient: Gleevec; Lasix; Drug, Unspecified
Adverse event in receiving Aldactone (Spironolactone)
Reported by a consumer/non-health professional from France on 2007-10-05
Patient:
Adverse reactions / side effects: Phlebitis, Pulmonary Embolism, Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace
Dosage: 1.25 mg, qd
Administration route: Oral
Indication: Nephrotic Syndrome
Lasix
Dosage: unk, qd
Administration route: Oral
Indication: Nephrotic Syndrome
Thalidomide
Dosage: 200 mg, qd
Administration route: Oral
Indication: Multiple Myeloma
Aldactone
Dosage: 75 mg, qd
Administration route: Oral
Indication: Nephrotic Syndrome
Other drugs received by patient: Alkeran; Dexamethasone 0.5mg TAB; Previscan / 00789001 /
Adverse event in 58 year old male receiving Aldactone (Spironolactone)
Reported by a individual with unspecified qualification on 2007-10-04
Patient: 58 year old male
Adverse reactions / side effects: Rectal Haemorrhage
Adverse event resulted in: hospitalization
Suspect drug(s):
Ramipril
Administration route: Oral
Lasix
Administration route: Oral
Indication: Cardiac Failure
Previscan / 00789001 /
Administration route: Oral
Indication: Thrombosis
End date: 2006-10-13
Aldactone
Administration route: Oral
Indication: Cardiac Failure
Elisor
Administration route: Oral
Adverse event in 53 year old male receiving Aldactone (Spironolactone)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-04
Patient: 53 year old male
Adverse reactions / side effects: Hepatic Encephalopathy, Infection
Adverse event resulted in: hospitalization
Suspect drug(s):
Avlocardyl LP
Administration route: Oral
Actiskenan
Dosage: not provided
Administration route: Oral
Start date: 2006-07-05
End date: 2006-07-10
Stablon
Administration route: Oral
Indication: Depression
Aldactone
Administration route: Oral
Pentoxifylline
Administration route: Oral
Indication: Cirrhosis Alcoholic
Start date: 2006-01-06
End date: 2006-07-13
Dafalgan Codeine
Administration route: Oral
Start date: 2006-07-05
End date: 2006-07-10
Other drugs received by patient: Clamoxyl; Lantus; Duphalac; Vitamin B1 and B6; Novorapid
Adverse event in 57 year old male receiving Aldactone (Spironolactone)
Reported by a pharmacist from Japan on 2007-10-02
Patient: 57 year old male, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: White Blood Cell Count Decreased, Dyspnoea, Pericardial Effusion, Haemoglobin Decreased, Haematocrit Decreased, Thrombocytopenic Purpura, Platelet Count Decreased, Haemorrhagic Diathesis, Rash Maculo-Papular
Adverse event resulted in: life threatening event
Suspect drug(s):
Lasix
Dosage: 20 mg/day
Administration route: Oral
Indication: Cardiac Failure Congestive
Start date: 2007-06-12
End date: 2007-07-13
Aldactone
Dosage: 25 mg/day
Administration route: Oral
Indication: Cardiac Failure Congestive
Start date: 2007-06-27
End date: 2007-07-20
Tenormin
Dosage: 25 mg/day
Administration route: Oral
Indication: Atrial Fibrillation
Start date: 2004-04-01
End date: 2007-07-20
Micardis
Dosage: 20 mg/day
Administration route: Oral
Indication: Cardiac Failure Congestive
Start date: 2004-04-01
End date: 2007-07-20
Warfarin Sodium
Dosage: 3 mg/day
Administration route: Oral
Indication: Atrial Fibrillation
Start date: 2007-06-07
End date: 2007-07-09
Propylthiouracil
Dosage: 300 mg/day
Administration route: Oral
Start date: 1987-01-01
End date: 2007-07-12
Propylthiouracil
Dosage: 200 mg/day
Administration route: Oral
Start date: 2007-07-13
End date: 2007-07-20
Propylthiouracil
Dosage: 300 mg/day
Administration route: Oral
Start date: 2007-08-03
Mucosta
Dosage: 300 mg/day
Administration route: Oral
Indication: Gastric Mucosal Lesion
Start date: 2007-05-18
End date: 2007-07-13
Sigmart
Dosage: 15 mg/day
Administration route: Oral
Indication: Angina Pectoris
Start date: 2004-04-01
End date: 2007-07-13
Bepricor
Dosage: 150 mg/day
Administration route: Oral
Indication: Atrial Fibrillation
Start date: 2007-07-02
End date: 2007-07-20
Nitroderm
Dosage: 1 patch/day
Indication: Angina Pectoris
Start date: 2007-07-13
Amlodipine Besylate
Indication: Angina Pectoris
Start date: 2004-04-01
Aspirin
Dosage: 100mg
Administration route: Oral
End date: 2007-07-12
Other drugs received by patient: Unasyn; Gentacin
Adverse event in 59 year old female receiving Aldactone (Spironolactone)
Reported by a physician from Japan on 2007-10-01
Patient: 59 year old female
Adverse reactions / side effects: Pancreatitis Acute
Suspect drug(s):
Aldactone
Administration route: Oral
Indication: Cardiac Failure
Furosemide
Page 1 Next >>
|
